Jun 26, 2026
15 MIN READ

Your Guide to Weight Loss Medication: How Many Pens Come in a Box of Wegovy?

Wegovy comes in 4-pen starter boxes with specific doses, but many patients seek flexible options. PlexusDx compounded semaglutide injection starts at $149/month with no insurance required, HSA/FSA eligible, and personalized dosing guidance.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 26, 2026
15 MIN READ

your guide to weight loss medication: how many pens come in a box of wegovy? — PlexusDx GLP-1 education

Last reviewed: June 26, 2026

Last updated: June 26, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy pens typically arrive in packages of four prefilled injection devices, each containing a set dose designed for gradual titration over 16 weeks. However, prescription Wegovy often faces insurance denials, prior authorization delays, and high copays—barriers that push many patients toward compounded alternatives like PlexusDx semaglutide injection, which delivers the same active ingredient at transparent, flat monthly pricing.

Understanding Wegovy Pen Box Contents and Dosage Structure

A standard Wegovy box contains four prefilled pens arranged in a starter dose progression. Each pen holds a single dose: typically 0.25 mg, 0.5 mg, 1 mg, or 1.5 mg semaglutide. The manufacturer recommends injecting once weekly on the same day, following a 16-week titration schedule where patients advance to the next dose strength every four weeks. This step-wise approach allows the body to adapt to the medication while minimizing nausea and gastrointestinal side effects.

Once patients complete the starter box, they may continue with maintenance pens at their target dose—often 2.4 mg weekly, which is the highest approved dose for weight loss. Each pen holds exactly one week's dose, so monthly refills require four pens. The prefilled design eliminates the need for manual mixing or measuring, though it also restricts dose flexibility if a patient's response or tolerance profile differs from the standard protocol.

Why Many Patients Switch From Wegovy to Compounded Semaglutide

Insurance coverage for Wegovy remains unpredictable despite its FDA approval. Many patients face denials based on BMI cutoffs, lack of documented comorbidities, or restrictions on 'cosmetic' weight loss. Even when approved, copays often range from $200 to $500 per month, and prior authorization delays can stretch to weeks or months. PlexusDx compounded semaglutide injection removes these barriers entirely: no insurance required, no prior authorization, no membership fee, and transparent pricing starting at $149 per month across all dose levels.

Compounded semaglutide is manufactured by licensed 503A compounding pharmacies—regulated facilities that compound the identical active pharmaceutical ingredient (semaglutide) used in Wegovy. PlexusDx serves all 50 states and accepts HSA and FSA funds, making the medication accessible whether you're insured or self-pay. Patients also gain flexibility in dosing schedules: some work with their PlexusDx care team to extend titration timelines or adjust injection frequency based on individual response, something the rigid Wegovy pen structure doesn't allow.

How PlexusDx Compounded Semaglutide Simplifies Your Weight Loss Journey

PlexusDx semaglutide injection begins at $149 per month—a price that holds steady regardless of your dose escalation. Your dose may need to go up; your price won't. Each prescription includes detailed instructions tailored to your baseline weight, health history, and tolerance profile. Unlike Wegovy's standardized four-pen starter box, PlexusDx can customize your initial dose strength and titration pace based on your body's response and your lifestyle, reducing the risk of unmanageable side effects.

The medication arrives in either multi-dose vials (which you inject yourself using a supplied pen device) or as pre-filled syringes, depending on your preference and state regulations. PlexusDx-affiliated compounding pharmacies provide comprehensive injection training via video and live support, ensuring you feel confident administering your weekly dose. Refills are simple: text, call, or log into your patient portal, and your next month's supply ships directly to your door.

Precision Peptide Genetic Testing for Personalized Semaglutide Response

Some patients respond powerfully to semaglutide while others see modest results, and genetics play a significant role in this variation. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) analyzes 14 metabolic pathways and 150+ genetic insights related to your GLP-1 receptor signaling, appetite regulation, and fat storage genes. Key variants—such as GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—directly influence how your body responds to semaglutide therapy.

Armed with your genetic profile, your PlexusDx care team can predict whether you'll respond best to standard semaglutide dosing, whether a dual-compound approach (PlexusDx GLP-Squared, combining semaglutide and tirzepatide) may be more effective, or whether oral formulations suit your preference. This personalization transforms weight loss treatment from a one-size-fits-all box of four pens into a truly customized regimen backed by your unique biology.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How many pens are in a Wegovy starter box, and how often do I inject?

A Wegovy starter box contains four pens with progressively increasing doses (0.25 mg, 0.5 mg, 1 mg, 1.5 mg), each injected once weekly over 16 weeks. After the starter phase, patients typically continue with 2.4 mg pens weekly. PlexusDx compounded semaglutide offers the same weekly injection schedule but with flexible dosing and customizable titration timelines based on your tolerance.

Is compounded semaglutide the same active ingredient as Wegovy?

Yes. Both Wegovy and PlexusDx compounded semaglutide contain semaglutide, the same GLP-1 receptor agonist manufactured by licensed 503A compounding pharmacies under strict FDA oversight. The main differences are pricing, insurance requirements, and dosing flexibility—not the medication itself.

Why does PlexusDx compounded semaglutide cost less than Wegovy?

PlexusDx eliminates insurance overhead, prior authorization delays, and manufacturing markups by operating a direct-to-patient model. Your $149/month flat price covers the medication, compounding, and care coordination—no insurance needed, no copay surprises. PlexusDx also accepts HSA and FSA funds, further reducing out-of-pocket costs.

What if I have side effects with semaglutide injections?

Nausea, constipation, and appetite suppression are common early side effects that typically subside within weeks as your body adjusts. PlexusDx care teams can slow your titration schedule, adjust injection timing, or recommend supportive strategies (hydration, ginger, fiber intake). If injections persistently cause issues, oral semaglutide or other formulations may be better alternatives.

How does the Precision Peptide Genetic Test help predict my semaglutide response?

The test analyzes genetic variants in your GLP-1 receptor, appetite-suppression pathways, and fat-storage genes to predict whether standard semaglutide will work optimally for you or whether a dual-compound approach (GLP-Squared) may be more effective. This personalization, available for $99 after your first treatment month, helps your PlexusDx team optimize your regimen before trial-and-error dosing wastes time.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves